For ORal Use in Dogs Only

INDICATIONS: Incurin Tbalets are indicated for the control of estrogen-responsive urinary incontinence in ovariohysterectomized female dogs.

WARNINGS:
HUMAN WARNNGS: Not for human use. Keep out of the reach of children. Women who are of child-bearing age or those who are breastfeeding should use caution when administering INCURIN Tablets. Wash your hands with soap and water after administration to avoid exposre to the drug. Consult a physician in case of accidental ingestion by humans.

ANIMAL WARNINGS: Some estrogens have been associated with bone marrow changes and an increased risk of mammary tumors. However, target animal safety study results and foreign post-market pharmacovigilance data for INCURIN Tablets have shown that estrial-treated dogs are at low risk for developing these conditions.

PRECAUTIONS: Evaluation factiors contributing to urinary incontinence should be considered prior of administration of INCURIN Tablets. Do not use with other estrogens. The concomitant use of INCURIN Tablets other estrogens has not been evaluated. The concomitant use of INCURIn Tablets with glucocorticoids has not been evaluated. The use of INCURIN Tablets in dogs with liver disease has not been evaluated. The safe use of INCURIn Tablets has not been evaluated in intact female dogs, pregnant or lactating dogs, and dogs less than 1 year of age.